VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. Blood. 2016 12 29; 128(26):3083-3100.
View in:
PubMed
subject areas
Antigens, CD20
Antigens, Neoplasm
Antineoplastic Combined Chemotherapy Protocols
B-Lymphocytes
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Germinal Center
Humans
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Models, Biological
Multivariate Analysis
Mutation
NF-kappa B
Prognosis
Programmed Cell Death 1 Receptor
Protein Transport
Proto-Oncogene Proteins c-myc
Risk Factors
RNA, Messenger
Survival Analysis
Tetraspanins
Treatment Outcome
Tumor Suppressor Protein p53
authors with profiles
L JEFFREY MEDEIROS
KEN HE YOUNG
ZIJUN XU-MONETTE